CIK 0001828673
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
HCW Biologics Inc.
Sign in to watch- Ticker
- HCWB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825024477
- Phone
- +1 954-842-2024
- Business address
- 2929 N COMMERCE PKWY, MIRAMAR, FL, 33025
- 4 Other disposition 10% owner disposed of 3,587,659 shares (other)
- 4/A Open-market buy Chief Financial Officer bought 10,000 shares at $4.40 ($43,979)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 3,830 shares at $3.93 ($15,070)
- 4 Open-market buy Chief Executive Officer bought 18,500 shares at an average $3.85 ($71,190)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 3,611 shares at $4.10 ($14,821)
- 4 Open-market buy SVP of Business Development bought 13,458 shares at an average $4.03 ($54,226)
- 4/A Open-market buy SVP of Business Development bought 10,532 shares at $4.29 ($45,218)
- 4 Open-market buy SVP of Business Development bought 10,532 shares at $4.25 ($44,785)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $4.40 ($43,979)
- 4 Conversion 10% owner acquired 3,587,661 shares (conversion)
- 4 Open-market buy Director bought 125,000 shares at $8.00 ($1,000,000)
- 4 Open-market buy See Remarks bought 12,500 shares at $8.00 ($100,000)
- 4 Open-market buy SVP of Business Development bought 31,250 shares at $8.00 ($250,000)
- 4 Open-market buy Chief Financial Officer bought 25,000 shares at $8.00 ($200,000)
Page 5 of 6 · 109 filings